DOAC users with eGFRs less than 60 mL/min/1.73m2 had a 23% higher risk for bleeding than warfarin users.
Insufficient evidence for adding to traditional CVD risk assessment in asymptomatic adults.
Association seen between marital status and risk, prognosis of coronary heart disease or stroke
Apixaban recipients had a 28% lower risk for major bleeding compared with patients treated with warfarin.
Composite outcome occurred in 12.9%; 50.1% of events in second to fifth years.
Lower incidence of major cardiovascular events with Mediterranean diet supplemented with oil, nuts.
And evidence insufficient to recommend ECG screen for asymptomatic adults at intermediate or high risk.
mHealth programs generally improve overall cardiovascular disease risk, at least in the short term.
Men with erectile dysfunction (ED) are almost twice as likely to experience a cardiovascular event as those without ED.
Generally moderate- or low-quality evidence for preventive benefits, no effect, or increased risk
Particulate matter less than 2.5 m in diameter linked to higher sudden cardiac death risk in women
SAD cause of considerable proportion of deaths in CHD patients without severe systolic dysfunction
Findings show MHO is transient, so not a reliable predictor of lower cardiovascular risk in the future
Aortic distensibility independently linked to concentric left ventricular remodeling
FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization.
Increased risk of CVD for achieved systolic blood pressure of 120 versus 130 or 140 mm Hg
Older patients who had more frequent nephrology visits prior to initiating dialysis had a lower incidence of atrial fibrillation in the year after initiating dialysis compared with those who did not.
Benefit of exercise against cardiovascular disease notable even among those at high genetic risk
Social isolation linked to increased mortality among individuals with history of AMI or stroke
Environmental lead exposure tied to all-cause, cardiovascular disease, ischemic heart disease mortality.
But no mortality risk reduction associated with weight loss in individuals with coronary heart disease
Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization.
After adjustment for hormone therapy use in women, associations no longer differed by sex
All-cause and cardiovascular mortality risks were 22% and 34% higher among febuxostat-treated patients vs allopurinol recipients.
Individuals who had a stroke or transient ischemic attack at age 60 to 64 had a 2-fold higher risk of UUI at age 68 years, a British study found.
Cardiac MR accurately diagnoses; myocardial scars may affect 8% of women with non-obstructive CAD
In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.
A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea.
Vitamin D levels increased from 13.2 to 33.7 ng/mL in nondialysis CKD patients treated with 50,000 units of cholecalciferol weekly for 12 weeks.
Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease
Renal and Urology News Articles
- FDA Approves Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
- Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer
- Bladder Hydrodistention May Ease Nocturia in Interstitial Cystitis
- Overnight Saline Irrigation May Prevent Early NMIBC Recurrence
- 5 Key Steps to Grow Your New Nephrology or Urology Practice
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)